Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Male Hypogonadism Market?

The market size for male hypogonadism has witnessed significant expansion in the past few years. Projected growth from $3.75 billion in 2024 to $3.95 billion in 2025 signifies a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historical period include an ageing population, increased awareness and diagnosis, lifestyle changes, chronic diseases, and treatment-seeking behavior.

There is an anticipated robust expansion in the male hypogonadism market over the upcoming years, with predictions estimating it to reach $4.99 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.0%. This projected growth throughout the forecast span can be credited to an escalating awareness, the increasing presence of lifestyle-related conditions, novel therapy innovations, a focus on men’s health, telemedicine advancements, and improved healthcare access. Key trends within the forecast period incorporate the inclusion of psychological and sexual health, the investigation into nutraceuticals and lifestyle modifications, market growth in developing economies, concerted research efforts, and an emphasis on long-term safety and monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

Which Factor Is Shaping The Future Of The Male Hypogonadism Market?

The growing rates of infertility are likely to fuel the expansion of the male hypogonadism market. Infertility is a medical condition marked by a failure to conceive after one year or more of regular, unprotected sexual activity, affecting either the male or female reproductive systems. Male hypogonadism, which may result in lower sperm production and infertility, is one of the possible sources of male infertility. Consequently, the rising incidence of male infertility is anticipated to stimulate the growth of the male hypogonadism market. For example, in February 2024, the Office for National Statistics, a UK governmental agency, reported that the overall infertility rate (TFR) increased to 1.49 children per woman in 2022, up from 1.55 in 2021. Hence, the spike in the infertility rate is prompting the growth of the male hypogonadism market.

What Is The Segment-Wise Breakdown Of The Male Hypogonadism Market?

The male hypogonadism market covered in this report is segmented –

1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types

2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries

3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

Subsegments:

1) By Klinefelter’s Syndrome: 47,XXY Syndrome, Other Variants

2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome

3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders

4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

Which Trends Are Redefining The Future Landscape Of The Male Hypogonadism Industry?

The emergence of innovative products is a significant trend gaining traction in the male hypogonadism market. Firms involved in this market are introducing novel products to maintain their competitive stance. For example, in June 2022, Halozyme, an American biotech company, unveiled Tlando, an oral solution for testosterone replacement therapy in male hypogonadism. Tlando, which contains testosterone, holds the distinction of being the first oral testosterone remedy to receive FDA approval. It is prescribed to treat adult males who, due to specific medical conditions, exhibit low or absent levels of testosterone.

Which Companies Hold The Largest Market Share In The Male Hypogonadism Sector?

Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

How Does Regional Performance Compare Across The Male Hypogonadism Industry?

North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9969&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model